相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial
Derek R. McHaffie et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
Britta Weber et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Jeffrey S. Wefel et al.
NEURO-ONCOLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
Joel W. Neal
FUTURE ONCOLOGY (2010)
DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, INDEXES, AND TREATMENT OUTCOMES FOR PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES: A MULTI-INSTITUTIONAL ANALYSIS OF 4,259 PATIENTS
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy?
Patrick J. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer
Yosuke Togashi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy
Denise D. Correa et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118)
Jonathan P. S. Knisely et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The epidermal growth factor receptor: A role in repair of radiation-induced DNA damage
David J. Chen et al.
CLINICAL CANCER RESEARCH (2007)
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma
Andreas F. Hottinger et al.
NEUROLOGY (2007)
Clinical predictors of metastatic disease to the brain from non small cell lung carcinoma: Primary tumor size, cell type, and lymph node metastases
Amol Mujoomdar et al.
RADIOLOGY (2007)
Frequent EGFR mutations in brain metastases of lung adenocarcinoma
Shingo Matsumoto et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy
JF Fowler
ACTA ONCOLOGICA (2005)
Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial
E Verger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Cognitive functions in survivors of primary central nervous system lymphoma
DD Correa et al.
NEUROLOGY (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
MP Mehta et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
